Genovis AB (publ.) (STO: GENO)
Sweden
· Delayed Price · Currency is SEK 27.65
-0.40 (-1.43%)
Nov 19, 2024, 5:29 PM CET
Genovis AB (publ.) Revenue
Genovis AB (publ.) had revenue of 32.90M SEK in the quarter ending September 30, 2024, with 8.97% growth. This brings the company's revenue in the last twelve months to 130.57M, down -17.28% year-over-year. In the year 2023, Genovis AB (publ.) had annual revenue of 159.07M with 53.60% growth.
Revenue (ttm)
130.57M
Revenue Growth
-17.28%
P/S Ratio
13.84
Revenue / Employee
4.08M
Employees
37
Market Cap
1.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 159.07M | 55.51M | 53.60% |
| Dec 31, 2022 | 103.56M | 9.89M | 10.55% |
| Dec 31, 2021 | 93.68M | 32.65M | 53.49% |
| Dec 31, 2020 | 61.03M | 480.58K | 0.79% |
| Dec 31, 2019 | 60.55M | 25.98M | 75.16% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca PLC | 519.35B |
| Swedish Orphan Biovitrum AB (publ) | 25.44B |
| Sectra AB (publ) | 3.17B |
| Getinge AB (publ) | 33.59B |
| Camurus AB (publ) | 1.69B |
| Vitrolife AB (publ) | 3.56B |
| Medicover AB (publ) | 22.60B |
| Elekta AB (publ) | 18.12B |
Genovis AB (publ.) News
- 16 days ago - Genovis AB (OSTO:GENO) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus